BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22589540)

  • 1. Tyrosine kinase Btk is required for NK cell activation.
    Bao Y; Zheng J; Han C; Jin J; Han H; Liu Y; Lau YL; Tu W; Cao X
    J Biol Chem; 2012 Jul; 287(28):23769-78. PubMed ID: 22589540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-γ.
    Guo Y; Luan L; Rabacal W; Bohannon JK; Fensterheim BA; Hernandez A; Sherwood ER
    J Immunol; 2015 Sep; 195(5):2353-64. PubMed ID: 26216888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions.
    Zhang M; Han Y; Han C; Xu S; Bao Y; Chen Z; Gu Y; Xia D; Cao X
    Hepatology; 2009 Nov; 50(5):1606-16. PubMed ID: 19821527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil development and function critically depend on Bruton tyrosine kinase in a mouse model of X-linked agammaglobulinemia.
    Fiedler K; Sindrilaru A; Terszowski G; Kokai E; Feyerabend TB; Bullinger L; Rodewald HR; Brunner C
    Blood; 2011 Jan; 117(4):1329-39. PubMed ID: 21063022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
    Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
    J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes.
    Korbel DS; Newman KC; Almeida CR; Davis DM; Riley EM
    J Immunol; 2005 Dec; 175(11):7466-73. PubMed ID: 16301654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells mediate severe liver injury in a murine model of halothane hepatitis.
    Dugan CM; Fullerton AM; Roth RA; Ganey PE
    Toxicol Sci; 2011 Apr; 120(2):507-18. PubMed ID: 21245496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma).
    Sun R; Gao B
    Gastroenterology; 2004 Nov; 127(5):1525-39. PubMed ID: 15521020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation.
    Liu J; Liu S; Xia M; Xu S; Wang C; Bao Y; Jiang M; Wu Y; Xu T; Cao X
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7814-9. PubMed ID: 23610400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia.
    Taneichi H; Kanegane H; Sira MM; Futatani T; Agematsu K; Sako M; Kaneko H; Kondo N; Kaisho T; Miyawaki T
    Clin Immunol; 2008 Feb; 126(2):148-54. PubMed ID: 18271077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of ascorbic acid impairs NK cell activity against ovarian cancer in a mouse model.
    Kim JE; Cho HS; Yang HS; Jung DJ; Hong SW; Hung CF; Lee WJ; Kim D
    Immunobiology; 2012 Sep; 217(9):873-81. PubMed ID: 22306178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential markers of NK-92 associated to cytotoxicity against K562 cells.
    Song X; Xu C; Wu X; Zhao X; Fan J; Meng S
    Biologicals; 2020 Nov; 68():46-53. PubMed ID: 32933840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells.
    Bao Y; Han Y; Chen Z; Xu S; Cao X
    Eur J Immunol; 2011 Mar; 41(3):657-68. PubMed ID: 21287550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide from
    Park HB; Hwang J; Zhang W; Go S; Kim J; Choi I; You S; Jin JO
    Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33302530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.
    Ciaglia E; Pisanti S; Picardi P; Laezza C; Malfitano AM; D'Alessandro A; Gazzerro P; Vitale M; Carbone E; Bifulco M
    J Leukoc Biol; 2013 Dec; 94(6):1207-19. PubMed ID: 23847096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA.
    Perrot I; Deauvieau F; Massacrier C; Hughes N; Garrone P; Durand I; Demaria O; Viaud N; Gauthier L; Blery M; Bonnefoy-Berard N; Morel Y; Tschopp J; Alexopoulou L; Trinchieri G; Paturel C; Caux C
    J Immunol; 2010 Aug; 185(4):2080-8. PubMed ID: 20639488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.